Alcon News
Most Popular Alcon Story
Potentia, Alcon ink AMD drug deal
Potentia Pharmaceuticals has signed a licensing and purchase agreement with eye drug company Alcon. Alcon gets a license to develop Potentia's leading drug candidate, POT-4, for the treatment of AMD. Read more...
Latest Headlines
- September 13, 2011
- February 1, 2010
- January 4, 2010
- October 23, 2009
- September 14, 2009
- January 13, 2009
- October 15, 2008
- July 23, 2008
- July 14, 2008
- April 14, 2008
- September 25, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
